Supplemental Table 10. Distribution of VLDL particle sizes (absolute values).
Baseline | Week 12 | |
---|---|---|
Cholesterol particle size of VLDL, nm | ||
Placebo | 42.79 (41.64, 44.12) | 42.45 (41.42, 44.09) |
Evolocumab | 42.64 (41.63, 43.81) | 42.87 (41.65, 44.37) |
Change from baseline, % | ||
Placebo | −0.29 (−2.66, 2.20) | |
Evolocumab | 0.34 (−1.95, 3.58) |
Abbreviation: VLDL, very low-density lipoprotein. Data are expressed as median (1st quartile, 3rd quartile).